Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies.
paper
Cited
Public
Unavailable
- Authors
- O'Keefe, Christine; McDevitt, Michael A; Maciejewski, Jaroslaw P
- Year
- 2010
- Journal
- Blood
- PMID
- 20107230
- DOI
- 10.1182/blood-2009-10-201848
- PMCID
- PMC2854422
Single nucleotide polymorphism arrays (SNP-A) have recently been widely applied as a powerful karyotyping tool in numerous translational cancer studies. SNP-A complements traditional metaphase cytogenetics with the unique ability to delineate a previously hidden chromosomal defect, copy neutral loss of heterozygosity (CN-LOH). Emerging data demonstrate that selected hematologic malignancies exhibit abundant CN-LOH, often in the setting of a normal metaphase karyotype and no previously identified clonal marker. In this review, we explore emerging biologic and clinical features of CN-LOH relevant to hematologic malignancies. In myeloid malignancies, CN-LOH has been associated with the duplication of oncogenic mutations with concomitant loss of the normal allele. Examples include JAK2, MPL, c-KIT, and FLT3. More recent investigations have focused on evaluation of candidate genes contained in common CN-LOH and deletion regions and have led to the discovery of tumor suppressor genes, including c-CBL and family members, as well as TET2. Investigations into the underlying mechanisms generating CN-LOH have great promise for elucidating general cancer mechanisms. We anticipate that further detailed characterization of CN-LOH lesions will probably facilitate our discovery of a more complete set of pathogenic molecular lesions, disease and prognosis markers, and better understanding of the initiation and progression of hematologic malignancies.
No figures extracted from this document.
No chunks โ full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | 2012 | 22561516 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Chromosome Karyotyping in Hematological Malignancies: Current Status and Future Directions. | Xu CY et al. | โ | 2026 | โ |
| Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia. | Lai A et al. | โ | 2026 | โ |
| Copy-Neutral Loss of Heterozygosity in Myelofibrosis: Parallel Evaluation with Optical Genome Mapping and Single-Nucleotide Polymorphism Arrays. | Dรญaz-Gonzรกlez ร et al. | โ | 2026 | โ |
| Points to consider for the next-generation-sequencing-based detection of copy-number abnormalities (CNAs) and balanced chromosomal rearrangements in neoplastic disorders: A statement of the American College of Medical Genetics and Genomics (ACMG). | Schieffer KM et al. | โ | 2026 | โ |
| Abnormalities in Chromosomes 5 and 7 in Myelodysplastic Syndrome and Acute Myeloid Leukemia. | Kendrick TS et al. | โ | 2025 | โ |
| Abnormal RH antigen expression in myeloid malignancies with MPL mutation, CSF3R mutation, or 1p deletion: Evidence of two distinct mechanisms. | Bourgeois R et al. | โ | 2025 | โ |
| A clinical guide to TP53 mutations in myeloid neoplasms. | Urrutia S et al. | โ | 2025 | โ |
| Bayesian Phylogenetic Lineage Reconstruction with Loss of Heterozygosity Mutations Derived from Single-Cell RNA Sequencing. | Anderson DJ et al. | โ | 2025 | โ |
| Immune Escape of Acute Myeloid Leukemia after Transplantation. | Ho NHJG et al. | โ | 2025 | โ |
| Patterns and drivers of 43,617 mosaic chromosomal alterations in blood | Tang D et al. | โ | 2025 | โ |
| Spontaneous and environment induced genomic alterations in yeast model. | Li KJ et al. | โ | 2025 | โ |
| Association of Mosaic Chromosomal Alterations and Genetic Factors with the Risk of Cirrhosis. | Ge X et al. | โ | 2024 | โ |
| Genomic Mosaicism of the Brain: Origin, Impact, and Utility. | Graham JH et al. | โ | 2024 | โ |
| Inferring allele-specific copy number aberrations and tumor phylogeography from spatially resolved transcriptomics. | Ma C et al. | โ | 2024 | โ |
| Tricking the trickster: precision medicine approaches to counteract leukemia immune escape after transplant. | Tameni A et al. | โ | 2024 | โ |
| Cytogenomic features of Richter transformation. | Woroniecka R et al. | โ | 2023 | โ |
| Genome-Enabled Insights into Downy Mildew Biology and Evolution. | Fletcher K et al. | โ | 2023 | โ |
| Identification of copy neutral loss of heterozygosity on chromosomes 1p, 1q, and 6p among nonsyndromic cleft lip and/or without cleft palate with hypodontia. | Ghazali N et al. | โ | 2023 | โ |
| Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia. | Valkama A et al. | โ | 2023 | โ |
| Pan-cancer analysis of whole-genome doubling and its association with patient prognosis. | Kikutake C et al. | โ | 2023 | โ |
| Prader-Willi and Angelman Syndromes: Mechanisms and Management. | Ma VK et al. | โ | 2023 | โ |
| Refined cytogenetic IPSS-R evaluation by the use of SNP array in a cohort of 290 MDS patients. | Scarpelli I et al. | โ | 2023 | โ |
| Analysis of somatic copy number alterations in biliary tract carcinoma using a single nucleotide polymorphism array. | Shioi Y et al. | โ | 2022 | โ |
| Comparison of the copy-neutral loss of heterozygosity identified from whole-exome sequencing data using three different tools. | Lee GT et al. | โ | 2022 | โ |
| Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases. | Kakuta Y et al. | โ | 2022 | โ |
| Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling. | Wu LR et al. | โ | 2022 | โ |
| Guiding the global evolution of cytogenetic testing for hematologic malignancies. | Akkari YMN et al. | โ | 2022 | โ |
| Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls. | Simkin D et al. | โ | 2022 | โ |
| ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected. | Boutin J et al. | โ | 2022 | โ |
| Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity. | Tuveri S et al. | โ | 2022 | โ |
| [Progress of heterozygosity loss in HLA region after allogeneic stem cell transplantation for leukemia]. | Lin MH et al. | โ | 2022 | โ |
| Relationship of microsatellite instability to mismatch repair deficiency in malignant tumors of dogs. | Inanaga S et al. | โ | 2022 | โ |
| Role of Radiation Based Conditioning Regimens in Patients With High-Risk AML Undergoing Allogenic Transplantation in Remission or Active Disease and Mechanisms of Post-Transplant Relapse. | Salhotra A et al. | โ | 2022 | โ |
| Simultaneous brain cell type and lineage determined by scRNA-seq reveals stereotyped cortical development. | Anderson DJ et al. | โ | 2022 | โ |
| A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencing. | Wang WH et al. | โ | 2021 | โ |
| Characterizing allele- and haplotype-specific copy numbers in single cells with CHISEL. | Zaccaria S et al. | โ | 2021 | โ |
| Clinical significance and mechanisms associated with segmental UPD. | Papenhausen PR et al. | โ | 2021 | โ |
| Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies. | Jiang L et al. | โ | 2021 | โ |
| Copy neutral absence of heterozygosity on chromosome 15 distal long arm: A surrogate marker for Prader-Willi/Angelman syndromes? | Ortega V et al. | โ | 2021 | โ |
| Copy Number Changes and Allele Distribution Patterns of Chromosome 21 in B Cell Precursor Acute Lymphoblastic Leukemia. | Abbasi MR et al. | โ | 2021 | โ |
| CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells. | Boutin J et al. | โ | 2021 | โ |
| Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing. | Zhang Z et al. | โ | 2021 | โ |
| [Mechanism of relapse and its therapeutic strategies after allogeneic hematopoietic stem cell transplantation]. | Wu HW et al. | โ | 2021 | โ |
| Molecular Changes in Retinoblastoma beyond <i>RB1</i>: Findings from Next-Generation Sequencing. | Francis JH et al. | โ | 2021 | โ |
| Pan cancer patterns of allelic imbalance from chromosomal alterations in 33 tumor types. | Sivakumar S et al. | โ | 2021 | โ |
| Somatic mosaicism in inherited bone marrow failure syndromes. | Gutierrez-Rodrigues F et al. | โ | 2021 | โ |
| Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance. | Mikkelsen SU et al. | โ | 2021 | โ |
| Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy. | Zhang X et al. | โ | 2021 | โ |
| TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics. | Guan Y et al. | โ | 2021 | โ |
| The Progenetix oncogenomic resource in 2021. | Huang Q et al. | โ | 2021 | โ |
| The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome. | Ou Y et al. | โ | 2021 | โ |
| Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype. | Ibรกรฑez M et al. | โ | 2020 | โ |
| Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumor. | Quevedo R et al. | โ | 2020 | โ |
| Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies. | Ronaghy A et al. | โ | 2020 | โ |
| Copy number assessment in the genomic analysis of CNS neoplasia: An evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors. | Neill SG et al. | โ | 2020 | โ |
| Decreased copy-neutral loss of heterozygosity in African American colorectal cancers. | Augustus GJ et al. | โ | 2020 | โ |
| Detection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing. | Weisheit I et al. | โ | 2020 | โ |
| Hundreds of thousands of cell generations reveal a treasure chest of genome alterations. | Argueso JL et al. | โ | 2020 | โ |
| Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation. | Rovatti PE et al. | โ | 2020 | โ |
| Monogenic and polygenic inheritance become instruments for clonal selection. | Loh PR et al. | โ | 2020 | โ |
| Mosaicism in Human Health and Disease. | Thorpe J et al. | โ | 2020 | โ |
| Paroxysmal nocturnal hemoglobinuria caused by CN-LOH of constitutional PIGB mutation and 70-kbp microdeletion on 15q. | Langemeijer S et al. | โ | 2020 | โ |
| Renal angiomyolipoma (AML) harboring a missense mutation of <i>TSC2</i> with copy-neutral loss of heterozygosity (CN-LOH). | Idogawa M et al. | โ | 2020 | โ |
| Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes. | Xiao X et al. | โ | 2020 | โ |
| Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond <i>SMARCA4</i> Mutations: A Comprehensive Genomic Analysis. | Auguste A et al. | โ | 2020 | โ |
| Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay. | Chen C et al. | โ | 2019 | โ |
| Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome. | Kenawy N et al. | โ | 2019 | โ |
| Cytogenetic evolution in myeloproliferative neoplasms with different molecular abnormalities. | Kim SY et al. | โ | 2019 | โ |
| Microarray-based comparative genomic hybridisation reveals additional recurrent aberrations in adult patients evaluated for myelodysplastic syndrome with normal karyotype. | Ouahchi I et al. | โ | 2019 | โ |
| Mosaicism by somatic non-functional mutations: one cell lineage at a time. | Flegel WA | โ | 2019 | โ |
| Pretransplant HLA typing revealed loss of heterozygosity in the major histocompatibility complex in a patient with acute myeloid leukemia. | Lobashevsky AL et al. | โ | 2019 | โ |
| Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers. | Torabi K et al. | โ | 2019 | โ |
| SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain. | Sinclair PB et al. | โ | 2019 | โ |
| Somatic mosaicisms of chromosome 1 at two different stages of ontogenetic development detected by Rh blood group discrepancies. | Dauber EM et al. | โ | 2019 | โ |
| The non-random landscape of somatically-acquired uniparental disomy in cancer. | Erola P et al. | โ | 2019 | โ |
| Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group. | Xu X et al. | โ | 2018 | โ |
| Characterization of phenotypic variation and genome aberrations observed among Phytophthora ramorum isolates from diverse hosts. | Elliott M et al. | โ | 2018 | โ |
| Classification of Uniparental Isodisomy Patterns That Cause Autosomal Recessive Disorders: Proposed Mechanisms of Different Proportions and Parental Origin in Each Pattern. | Niida Y et al. | โ | 2018 | โ |
| Detecting, quantifying, and discriminating the mechanism of mosaic chromosomal aneuploidies using MAD-seq. | Kong Y et al. | โ | 2018 | โ |
| Epidemiology and biology of relapse after stem cell transplantation. | Horowitz M et al. | โ | 2018 | โ |
| High Frequency of Copy-Neutral Loss of Heterozygosity in Patients with Myelofibrosis. | Rego de Paula Junior M et al. | โ | 2018 | โ |
| Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses. | Vetro C et al. | โ | 2018 | โ |
| Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. | Yeung CCS et al. | โ | 2018 | โ |
| Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. | Loh PR et al. | โ | 2018 | โ |
| LRBA Deficiency in a Patient With a Novel Homozygous Mutation Due to Chromosome 4 Segmental Uniparental Isodisomy. | Soler-Palacรญn P et al. | โ | 2018 | โ |
| Molecular profiling and genome-wide analysis based on somatic copy number alterations in advanced colorectal cancers. | Sugai T et al. | โ | 2018 | โ |
| Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families. | Dominguez-Valentin M et al. | โ | 2018 | โ |
| Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. | Haas OA | โ | 2018 | โ |
| SNP-array lesions in core binding factor acute myeloid leukemia. | Duployez N et al. | โ | 2018 | โ |
| FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of Heterozygosity. | Gaymes TJ et al. | โ | 2017 | โ |
| Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial. | Stevens-Kroef MJ et al. | โ | 2017 | โ |
| Genomic landscape of copy number variation and copy neutral loss of heterozygosity events in equine sarcoids reveals increased instability of the sarcoid genome. | Pawlina-Tyszko K et al. | โ | 2017 | โ |
| Germline large genomic alterations on 7q in patients with multiple primary cancers. | Villacis RA et al. | โ | 2017 | โ |
| Identify latent chromosomal aberrations relevant to myelodysplastic syndromes. | Song Q et al. | โ | 2017 | โ |
| Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia. | Palau A et al. | โ | 2017 | โ |
| Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development. | Villacis RAR et al. | โ | 2017 | โ |
| Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome. | da Silva FB et al. | โ | 2017 | โ |
| What Is the Clinical Utility of Repeat SNP Array Testing in the Follow-up of Myeloid Neoplasms?: A Retrospective Analysis of 44 Patients With Serial SNP Arrays. | Basha B et al. | โ | 2017 | โ |
| Whole-Exome Sequencing Study of Thyrotropin-Secreting Pituitary Adenomas. | Sapkota S et al. | โ | 2017 | โ |
| Characterizing Genetic Transitions of Copy Number Alterations and Allelic Imbalances in Oral Tongue Carcinoma Metastasis. | Morita T et al. | โ | 2016 | โ |
| Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas. | Labussiรจre M et al. | โ | 2016 | โ |
| Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance. | Evans AG et al. | โ | 2016 | โ |
| Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes. | Svobodova K et al. | โ | 2016 | โ |
| Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies. | McKerrell T et al. | โ | 2016 | โ |
| Generation of KCL040 clinical grade human embryonic stem cell line. | Jacquet L et al. | โ | 2016 | โ |
| Genetic-pathologic characterization of myeloproliferative neoplasms. | Kim Y et al. | โ | 2016 | โ |
| Genetic Reversion via Mitotic Recombination in Ichthyosis with Confetti due to a KRT10 Polyalanine Frameshift Mutation. | Lim YH et al. | โ | 2016 | โ |
| Guidelines for genomic array analysis in acquired haematological neoplastic disorders. | Schoumans J et al. | โ | 2016 | โ |
| Patterns and frequencies of acquired and constitutional uniparental isodisomies in pediatric and adult B-cell precursor acute lymphoblastic leukemia. | Lundin KB et al. | โ | 2016 | โ |
| Somatic mutation in the HLA-B gene of a patient with acute myelogenous leukaemia. | Planelles D et al. | โ | 2016 | โ |
| The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia. | Carrasco Salas P et al. | โ | 2016 | โ |
| Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies. | Nanaji NM et al. | โ | 2015 | โ |
| Cross-laboratory validation of the OncoScanยฎ FFPE Assay, a multiplex tool for whole genome tumour profiling. | Foster JM et al. | โ | 2015 | โ |
| Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression. | Gu J et al. | โ | 2015 | โ |
| Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q). | Zhang R et al. | โ | 2015 | โ |
| High resolution single nucleotide polymorphism array reveals cryptic indicating information about myelodysplastic syndrome-related myeloid malignancies. | Chi K et al. | โ | 2015 | โ |
| Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer. | Torabi K et al. | โ | 2015 | โ |
| Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia. | Gronseth CM et al. | โ | 2015 | โ |
| SNPs Array Karyotyping in Non-Hodgkin Lymphoma. | Etebari M et al. | โ | 2015 | โ |
| The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines. | Canham MA et al. | โ | 2015 | โ |
| Analysis for loss of heterozygosity on chromosome arm 13q by STR analysis or SNP sequencing can replace analysis of FLT3-ITD to detect patients with prognostically adverse AML. | Schnittger S et al. | โ | 2014 | โ |
| Cancer cytogenetics: methodology revisited. | Wan TS | โ | 2014 | โ |
| Chromosome microarrays in diagnostic testing: interpreting the genomic data. | Peters GB et al. | โ | 2014 | โ |
| Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses. | Koh KN et al. | โ | 2014 | โ |
| Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity. | Witter K et al. | โ | 2014 | โ |
| Concurrence of B-lymphoblastic leukemia and myeloproliferative neoplasm with copy neutral loss of heterozygosity at chromosome 1p harboring a MPL W515S mutation. | Tao J et al. | โ | 2014 | โ |
| Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML. | Stirewalt DL et al. | โ | 2014 | โ |
| Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma. | Marescalco MS et al. | โ | 2014 | โ |
| Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma. | Huang WT et al. | โ | 2014 | โ |
| Germline DNA variations in breast cancer predisposition and prognosis: a systematic review of the literature. | Sapkota Y | โ | 2014 | โ |
| Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice. | Akada H et al. | โ | 2014 | โ |
| Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia. | Gรณmez-Seguรญ I et al. | โ | 2014 | โ |
| The Biology and Targeting of FLT3 in Pediatric Leukemia. | Annesley CE et al. | โ | 2014 | โ |
| Transformed aggressive ฮณฮด-variant T-cell large granular lymphocytic leukemia with acquired copy neutral loss of heterozygosity at 17q11.2q25.3 and additional aberrations. | Zhang L et al. | โ | 2014 | โ |
| Translocation (8;21) acute myeloid leukemia presenting as severe aplastic anemia. | Purev E et al. | โ | 2014 | โ |
| Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms. | Rumi E et al. | โ | 2013 | โ |
| American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders. | Cooley LD et al. | โ | 2013 | โ |
| Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category. | Huh J et al. | โ | 2013 | โ |
| Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management. | Ofran Y et al. | โ | 2013 | โ |
| Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia. | Poulain S et al. | โ | 2013 | โ |
| Genomic studies have identified multiple mechanisms of genetic changes in Waldenstrรถm macroglobulinemia. | Poulain S et al. | โ | 2013 | โ |
| Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence. | Sapkota Y et al. | โ | 2013 | โ |
| High-resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B-cell lymphoma and its large cell variant. | Flossbach L et al. | โ | 2013 | โ |
| MYD88 L265P mutation in Waldenstrom macroglobulinemia. | Poulain S et al. | โ | 2013 | โ |
| Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease. | Singh NR et al. | โ | 2013 | โ |
| PTCH1 gene polymorphisms in ovarian tumors: potential protective role of c.3944T allele. | Musani V et al. | โ | 2013 | โ |
| Single-nucleotide polymorphism-array improves detection rate of genomic alterations in core-binding factor leukemia. | Costa AR et al. | โ | 2013 | โ |
| Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing. | Arenillas L et al. | โ | 2013 | โ |
| Stem cells: will they ever be the same? | Pryzhkova MV | โ | 2013 | โ |
| The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods. | Xu X et al. | โ | 2013 | โ |
| CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. | Makishima H et al. | โ | 2012 | โ |
| Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies. | McDevitt MA | โ | 2012 | โ |
| Copy number alteration and uniparental disomy analysis categorizes Japanese papillary thyroid carcinomas into distinct groups. | Matsuse M et al. | โ | 2012 | โ |
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | Laurie CC et al. | โ | 2012 | โ |
| Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes. | Jacoby MA et al. | โ | 2012 | โ |
| Epigenetic modification of the repair donor regulates targeted gene correction. | Humbert O et al. | โ | 2012 | โ |
| Genomic loss of mismatched human leukocyte antigen and leukemia immune escape from haploidentical graft-versus-leukemia. | Vago L et al. | โ | 2012 | โ |
| Molecular diagnosis of leukemia. | Mason J et al. | โ | 2012 | โ |
| Mutational determinants of epigenetic instablity in myeloid malignancies. | Jankowska AM et al. | โ | 2012 | โ |
| No threshold for the induction of chromosomal damage at clinically relevant low doses of X rays. | Boei JJ et al. | โ | 2012 | โ |
| Somatic mutations in the HLA genes of patients with hematological malignancy. | Smith AG et al. | โ | 2012 | โ |
| Targeted gene therapies: tools, applications, optimization. | Humbert O et al. | โ | 2012 | โ |
| Array CGH in human leukemia: from somatics to genetics. | van der Veken LT et al. | โ | 2011 | โ |
| Clinical utility of single nucleotide polymorphism arrays. | Schwartz S | โ | 2011 | โ |
| Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations. | Saeki H et al. | โ | 2011 | โ |
| Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations. | Kearney HM et al. | โ | 2011 | โ |
| Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. | Dickinson RE et al. | โ | 2011 | โ |
| Fanconi anemia. | Soulier J | โ | 2011 | โ |
| High-throughput genomic analysis in Waldenstrรถm's macroglobulinemia. | Poulain S et al. | โ | 2011 | โ |
| Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice. | Li L et al. | โ | 2011 | โ |
| Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. | Quentin S et al. | โ | 2011 | โ |
| Parent-specific copy number in paired tumor-normal studies using circular binary segmentation. | Olshen AB et al. | โ | 2011 | โ |
| Rapid high-resolution mapping of balanced chromosomal rearrangements on tiling CGH arrays. | Greisman HA et al. | โ | 2011 | โ |
| Temporal dissection of tumorigenesis in primary cancers. | Durinck S et al. | โ | 2011 | โ |
| Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. | Hu N et al. | โ | 2010 | โ |
| Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. | Choate KA et al. | โ | 2010 | โ |
| Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. | Smith AE et al. | โ | 2010 | โ |
| Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. | Makishima H et al. | โ | 2010 | โ |
| Prognosis of myelodysplastic syndromes. | Garcia-Manero G | โ | 2010 | โ |